ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 163 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $313,000 | -95.3% | 196,740 | -89.0% | 0.00% | -92.6% |
| Q3 2018 | $6,609,000 | -88.4% | 1,796,000 | -74.5% | 0.03% | -93.3% |
| Q3 2016 | $57,140,000 | -18.5% | 7,054,346 | -21.5% | 0.40% | -15.7% |
| Q2 2016 | $70,103,000 | -0.3% | 8,987,615 | -1.3% | 0.48% | -11.5% |
| Q1 2016 | $70,282,000 | -27.4% | 9,103,921 | +1.5% | 0.54% | -32.5% |
| Q4 2015 | $96,750,000 | +43.3% | 8,966,608 | -8.2% | 0.80% | +50.6% |
| Q3 2015 | $67,525,000 | -9.1% | 9,772,018 | +16.5% | 0.53% | +2.9% |
| Q2 2015 | $74,319,000 | +875.6% | 8,388,200 | +1248.8% | 0.52% | +871.7% |
| Q4 2014 | $7,618,000 | -27.2% | 621,900 | -40.7% | 0.05% | -32.9% |
| Q3 2014 | $10,460,000 | +152.5% | 1,048,100 | +91.5% | 0.08% | +192.6% |
| Q2 2014 | $4,142,000 | – | 547,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
| HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
| BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
| EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
| Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
| DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
| Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
| Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
| Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
| TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |